Standard Biotools (LAB) executive compensation, 2026 proxy

Michael Egholm, Ph.D., President, Chief Executive Officer, and Director, was paid $8.8M in fiscal 2025, up 6% from $8.3M the year before. The CEO-to-median-employee pay ratio was 72:1, on median employee pay of $123,327.

Filed
April 27, 2026
Annual meeting
June 17, 2026
Pay year
fiscal 2025
Named executives
3
CEO total pay
$8.8M+6% vs prior year
CEO to median employee
72:1median $123,327
CEO pay in equity
79%$7M in awards
Prior say-on-pay support
98%of votes cast
CEO Target Bonus
100%Percentage of base salary
Annual Incentive Payout
160%Percentage of target
Continuing Operations Revenue
$85.3MFor fiscal year 2025
Cash and Investments
$210.7MAs of December 31, 2025

How Ph.D. was paid

$8.8M in total for fiscal 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.

Salary8%Stock awards60%Option awards19%Non-equity incentive13%All other compensation0%

Named executive officers

ExecutiveTotal
Michael Egholm, Ph.D.President, Chief Executive Officer, and Director$8,823,502
Alex KimChief Financial Officer$4,005,165
Sean MackayChief Business Officer$1,692,543

What changed and why

  • $8.8MMichael Egholm received total compensation of $8,823,502 in fiscal 2025, compared to $8,337,044 in 2024.
  • 160%Cash incentive program awards were approved and paid out at 160% of target.
  • Michael Egholm did not receive a base salary increase for 2025.
  • 3%Alex Kim and Sean Mackay received base salary increases of approximately 3% for 2025.

About this page

Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.